within Pharmacolibrary.Drugs.ATC.A;

model A11GA01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0004,
    k12             = 4.0,
    k21             = 4.0
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A11GA01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ascorbic acid, also known as Vitamin C, is an essential water-soluble vitamin used for the prevention and treatment of scurvy and as an antioxidant. It is commonly used to boost immune function and is approved for use as a dietary supplement worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Padayatty, SJ, et al., &amp; Levine, M (2004). Vitamin C pharmacokinetics: implications for oral and intravenous use. <i>Annals of internal medicine</i> 140(7) 533–537. DOI:<a href=&quot;https://doi.org/10.7326/0003-4819-140-7-200404060-00010&quot;>10.7326/0003-4819-140-7-200404060-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15068981/&quot;>https://pubmed.ncbi.nlm.nih.gov/15068981</a></p></li><li><p>Duconge, J, et al., &amp; Riordan, NH (2008). Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. <i>Puerto Rico health sciences journal</i> 27(1) 7–19. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18450228/&quot;>https://pubmed.ncbi.nlm.nih.gov/18450228</a></p></li><li><p>Sebastian, S, et al., &amp; Vilapurathu, JK (2021). Effect of high-dose intravenous ascorbic acid on cancer patients following ketogenic diet. <i>Journal of cancer research and therapeutics</i> 17(6) 1583–1586. DOI:<a href=&quot;https://doi.org/10.4103/jcrt.JCRT_973_19&quot;>10.4103/jcrt.JCRT_973_19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34916403/&quot;>https://pubmed.ncbi.nlm.nih.gov/34916403</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A11GA01_1;
